Walleye Capital LLC Nevro Corp Call Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$4.71 - $10.1 $2,826 - $6,060	600 Added 15.79%	4,400 $24,000
Q2 2024 Aug 14, 2024	SELL	$7.96 - $13.59 $14,328 - $24,462	-1,800 Reduced 32.14%	3,800 $31,000
Q1 2024 May 15, 2024	BUY	$13.56 - $20.78 $75,936 - $116,368	5,600 New	5,600 $80,000
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $236,871 - $364,374	-3,100 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $18,456 - $27,330	-300 Reduced 8.82%	3,100 $267,000
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $197,336 - $227,765	3,400 New	3,400 $220,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $162M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.